| A compendium of RNA-binding motifs for decoding gene regulation D Ray, H Kazan, KB Cook, MT Weirauch, HS Najafabadi, X Li, ... Nature 499 (7457), 172-177, 2013 | 1489 | 2013 |
| YY1 is a structural regulator of enhancer-promoter loops AS Weintraub, CH Li, AV Zamudio, AA Sigova, NM Hannett, DS Day, ... Cell 171 (7), 1573-1588. e28, 2017 | 856 | 2017 |
| The dTAG system for immediate and target-specific protein degradation B Nabet, JM Roberts, DL Buckley, J Paulk, S Dastjerdi, A Yang, ... Nature chemical biology 14 (5), 431-441, 2018 | 717 | 2018 |
| ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing CC Warzecha, TK Sato, B Nabet, JB Hogenesch, RP Carstens Molecular cell 33 (5), 591-601, 2009 | 597 | 2009 |
| Transcription control by the ENL YEATS domain in acute leukaemia MA Erb, TG Scott, BE Li, H Xie, J Paulk, HS Seo, A Souza, JM Roberts, ... Nature 543 (7644), 270-274, 2017 | 297 | 2017 |
| Mutant NPM1 maintains the leukemic state through HOX expression L Brunetti, MC Gundry, D Sorcini, AG Guzman, YH Huang, ... Cancer cell 34 (3), 499-512. e9, 2018 | 239 | 2018 |
| Exploring targeted degradation strategy for oncogenic KRASG12C M Zeng, Y Xiong, N Safaee, RP Nowak, KA Donovan, CJ Yuan, B Nabet, ... Cell chemical biology 27 (1), 19-31. e6, 2020 | 209 | 2020 |
| Predictors of prognosis in patients with olfactory disturbance B London, B Nabet, AR Fisher, B White, MD Sammel, RL Doty Annals of neurology 63 (2), 159-166, 2008 | 195 | 2008 |
| Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma R Zeid, MA Lawlor, E Poon, JM Reyes, M Fulciniti, MA Lopez, TG Scott, ... Nature genetics 50 (4), 515-523, 2018 | 194 | 2018 |
| Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 M Zeng, NP Kwiatkowski, T Zhang, B Nabet, M Xu, Y Liang, C Quan, ... Elife 7, e39030, 2018 | 141 | 2018 |
| Rapid and direct control of target protein levels with VHL-recruiting dTAG molecules B Nabet, FM Ferguson, BKA Seong, M Kuljanin, AL Leggett, ML Mohardt, ... Nature communications 11 (1), 4687, 2020 | 137 | 2020 |
| UTX/KDM6A loss enhances the malignant phenotype of multiple myeloma and sensitizes cells to EZH2 inhibition T Ezponda, D Dupéré-Richer, CM Will, EC Small, N Varghese, T Patel, ... Cell reports 21 (3), 628-640, 2017 | 133 | 2017 |
| MELK is not necessary for the proliferation of basal-like breast cancer cells HT Huang, HS Seo, T Zhang, Y Wang, B Jiang, Q Li, DL Buckley, B Nabet, ... Elife 6, e26693, 2017 | 103 | 2017 |
| Discovery of a selective inhibitor of doublecortin like kinase 1 FM Ferguson, B Nabet, S Raghavan, Y Liu, AL Leggett, M Kuljanin, ... Nature chemical biology 16 (6), 635-643, 2020 | 92 | 2020 |
| Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo C Dubiella, BJ Pinch, K Koikawa, D Zaidman, E Poon, TD Manz, B Nabet, ... Nature chemical biology 17 (9), 954-963, 2021 | 91 | 2021 |
| Selective Mediator dependence of cell-type-specifying transcription MG Jaeger, B Schwalb, SD Mackowiak, T Velychko, A Hanzl, H Imrichova, ... Nature genetics 52 (7), 719-727, 2020 | 87 | 2020 |
| Synthetic lethal interaction of SHOC2 depletion with MEK inhibition in RAS-driven cancers R Sulahian, JJ Kwon, KH Walsh, E Pailler, TL Bosse, M Thaker, ... Cell reports 29 (1), 118-134. e8, 2019 | 71 | 2019 |
| A mutation in histone H2B represents a new class of oncogenic driver RL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ... Cancer discovery 9 (10), 1438-1451, 2019 | 69 | 2019 |
| Identification of a potent and selective covalent Pin1 inhibitor BJ Pinch, ZM Doctor, B Nabet, CM Browne, HS Seo, ML Mohardt, ... Nature chemical biology 16 (9), 979-987, 2020 | 58 | 2020 |
| TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma BKA Seong, NV Dharia, S Lin, KA Donovan, S Chong, A Robichaud, ... Cancer cell 39 (9), 1262-1278. e7, 2021 | 53 | 2021 |
